Literature DB >> 9818613

Risk factors for noncompliance with glaucoma follow-up visits in a residents' eye clinic.

O Kosoko1, H A Quigley, S Vitale, C Enger, L Kerrigan, J M Tielsch.   

Abstract

OBJECTIVE: This study aimed to identify factors associated with compliance with glaucoma follow-up visits.
DESIGN: Computer records of a university residents' eye clinic were reviewed to identify a random sample of all persons who had an examination with International Classification of Disease (ICD) 9 coding (ICD9) for glaucoma suspect or glaucoma during a 2-year period (1991-1993) to undergo telephone interview. PARTICIPANTS: Those who were seen at least every 6 months regardless of earlier return instructions were defined as compliant with follow-up (controls, n = 362). Those who had any lapse between visits of longer than 6 months were defined as noncompliant (cases, n = 362).
RESULTS: Interviews were completed for 196 cases and 242 controls. Noncompliant persons were significantly more likely to be suspects for glaucoma rather than to have definite glaucoma and to be dissatisfied with waiting time in the clinic (29.1% vs. 17.8%, P < 0.005) and to state that they did not take their glaucoma medications as prescribed (25.4% vs. 13.4%, P < 0.004). They also were less likely to have been prescribed eyedrop medication. A high percentage of both patients and controls knew that glaucoma can lead to blindness (85.2% and 88.4%, respectively). The most common reasons patients gave for not keeping follow-up visits were the perception that their eye problem was "not serious enough," the cost of examinations, and that the doctor did not tell them to come back.
CONCLUSION: Compliance with follow-up visits for glaucoma is associated with markers for early disease. Attempts to improve compliance might focus on improved communication of the seriousness of the disease and improvements in clinic waiting time.

Entities:  

Mesh:

Year:  1998        PMID: 9818613     DOI: 10.1016/S0161-6420(98)91134-4

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  25 in total

1.  Impact of a health communication intervention to improve glaucoma treatment adherence. Results of the interactive study to increase glaucoma adherence to treatment trial.

Authors:  Karen Glanz; Allen D Beck; Lucja Bundy; Susan Primo; Michael J Lynn; Julia Cleveland; Jessica A Wold; Katharina V Echt
Journal:  Arch Ophthalmol       Date:  2012-10

2.  Prevalence and determinants of non-adherence to topical hypotensive treatment in Dutch glaucoma patients.

Authors:  Christine M G Olthoff; Juliette G M M Hoevenaars; Bart W van den Borne; Carroll A B Webers; Jan S A G Schouten
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-09-19       Impact factor: 3.117

3.  Persistence with topical glaucoma therapy among newly diagnosed Japanese patients.

Authors:  Kenji Kashiwagi; Toshie Furuya
Journal:  Jpn J Ophthalmol       Date:  2013-10-25       Impact factor: 2.447

4.  Glaucoma Care of Prison Inmates at an Academic Hospital.

Authors:  Levi N Kanu; Inae Jang; Daniel J Oh; Manpreet S Tiwana; Amy A Mehta; Mark S Dikopf; Thasarat S Vajaranant; Ahmad A Aref; Deepak P Edward
Journal:  JAMA Ophthalmol       Date:  2020-04-01       Impact factor: 7.389

5.  Barriers to Glaucoma Medication Compliance Among Veterans: Dry Eye Symptoms and Anxiety Disorders.

Authors:  Jack Stringham; Noy Ashkenazy; Anat Galor; Sarah R Wellik
Journal:  Eye Contact Lens       Date:  2018-01       Impact factor: 2.018

Review 6.  Functional assessment of glaucoma: Uncovering progression.

Authors:  Rongrong Hu; Lyne Racette; Kelly S Chen; Chris A Johnson
Journal:  Surv Ophthalmol       Date:  2020-04-26       Impact factor: 6.048

7.  Assessment of patient opinions of different clinical tests used in the management of glaucoma.

Authors:  Stuart K Gardiner; Shaban Demirel
Journal:  Ophthalmology       Date:  2008-12       Impact factor: 12.079

8.  The association between compliance with recommended follow-up and glaucomatous disease severity in a county hospital population.

Authors:  Cindy Ung; Yohko Murakami; Elisa Zhang; Tatyana Alfaro; Monica Zhang; Michael I Seider; Kuldev Singh; Shan C Lin
Journal:  Am J Ophthalmol       Date:  2013-04-17       Impact factor: 5.258

9.  Knowledge, attitudes, and beliefs about dilated eye examinations among African-Americans.

Authors:  Nancy J Ellish; Renee Royak-Schaler; Susan R Passmore; Eve J Higginbotham
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-05       Impact factor: 4.799

10.  An exploratory study of factors influencing glaucoma treatment adherence.

Authors:  Jo Ellen Stryker; Allen Dale Beck; Susan A Primo; Katharina V Echt; Lucja Bundy; Grace Cho Pretorius; Karen Glanz
Journal:  J Glaucoma       Date:  2010-01       Impact factor: 2.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.